Urgent Field Safety Notice

N-acetyl-p-benzoquinone imine NAPQI Interference with ADVIA® Chemistry Fructosamine FRUC and Enzymatic Creatinine_2 ECRE_2 Assays Siemens Healthcare Diagnostics Inc.. All Rights

Mailing Number 13-99 GPF-003-6 V4.0 Effective: 2012-03-09 FIELD CORRECTION EFFECTIVENESS CHECK Potential Sampling Issue with Radiometer Blood Gas Analyzers This response form is to

--- Urgent Field Safety Notice CARESTREAM DRX-1 System Battery FSCA VIG-1317307-2012-00008 Device Modification or Replacement --- Date: 18 JUNE 2012 Attention: Potential DRX-1

In the meantime, we have identified certain mitigations preventing the issue from occurring: If your system is equipped with a VISITAG SURPOINTTM Module License: • Always work with

CL2015‐072_EU Page 1 of 4 URGENT FIELD SAFETY NOTICE Software Anomaly using enGen™ Laboratory Automation Systems Configured with enGen™ Select v5.0 and Custom or Select v3.2.2

DV December 2019 Urgent Field Safety Notice ACHC20-01.A.OUS.DV December 2019 Dimension Vista® Systems Phenindione Interference with Dimension Vista® Enzymatic Creatinine ECREA

Sincerely, Country BU Manager Enclosures: Increased Risk of Motor Stall and Loss of or Change in Therapy with Unapproved Drug Formulations Summary of Approved

--- Urgent Field Safety Notice Commercial name of the affected product: Zenith TX2 TAA Endovascular Graft with Pro- Form Proximal Component FSCA-identifier: FSCA-2014-03-31 Type